Am Fam Physician. 2022;105(1):online
Related Putting Prevention into Practice: Screening for Prediabetes and Type 2 Diabetes Mellitus
As published by the USPSTF.
|What does the USPSTF recommend?||Adults aged 35 to 70 years who have overweight or obesity:|
Screen for prediabetes and type 2 diabetes, and offer or refer patients with prediabetes to effective preventive interventions. Grade: B
|To whom does the recommendation apply?||Nonpregnant adults aged 35 to 70 years who have overweight or obesity and no symptoms of diabetes.|
|What's new?||The USPSTF has lowered the starting age of screening from 40 to 35 years.|
|How to implement this recommendation?||1. Assess risk:|
Obtain height and weight measurements to determine whether patient has overweight or obesity. Overweight and obesity are defined as a BMI ≥ 25 and ≥ 30, respectively.
If the patient is aged 35 to 70 years and has overweight or obesity.
Consider screening at an earlier age if the patient is from a population with a disproportionately high prevalence of diabetes (American Indian/Alaska Native, Black, Hispanic/Latino, Native Hawaiian/Pacific Islander), and at a lower BMI (≥ 23) if the patient is Asian American.
Screening tests for prediabetes and type 2 diabetes include measurement of fasting plasma glucose or HbA1c level or an oral glucose tolerance test.
|How often?||The optimal screening interval for adults with an initial normal glucose test result is uncertain. Screening every 3 years may be a reasonable approach for adults with normal blood glucose levels.|
|What are other relevant USPSTF recommendations?||The USPSTF has made a recommendation on behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults with a BMI ≥ 30. This recommendation is available at www.uspreventiveservicestaskforce.org.|
|Where to read the full recommendation statement?||Visit the USPSTF website or the JAMA website (https://jamanetwork.com/collections/44068/united-states-preventive-services-task-force) to read the full recommendation statement. This includes more details on the rationale of the recommendation, including benefits and harms; supporting evidence; and recommendations of others.|